ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VRTX Vertex Pharmaceuticals Inc

401.08
0.92 (0.23%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Vertex Pharmaceuticals Inc NASDAQ:VRTX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.92 0.23% 401.08 400.68 408.70 405.665 397.59 401.50 1,063,962 01:00:00

Vertex to Present at the Credit Suisse Healthcare Conference on November 7

02/11/2017 8:01pm

Business Wire


Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Vertex Pharmaceuticals Charts.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the Credit Suisse Healthcare Conference on Tuesday, November 7, 2017 at 10:35 a.m. ET.

Management’s remarks will be available live through Vertex’s website at www.vrtx.com in the “Investors” section under the “News and Events” page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

Founded in 1989 in Cambridge, Mass., Vertex's headquarters is now located in Boston's Innovation District. Today, the company has research and development sites and commercial offices in the United States, Europe, Canada and Australia. Vertex is consistently recognized as one of the industry's top places to work, including being named to Science magazine's Top Employers in the life sciences ranking for eight years in a row.

For additional information and the latest updates from the company, please visit www.vrtx.com.

(VRTX-WEB)

Vertex Pharmaceuticals IncorporatedInvestors:Michael Partridge, 617-341-6108orEric Rojas, 617-961-7205orZach Barber, 617-341-6470

1 Year Vertex Pharmaceuticals Chart

1 Year Vertex Pharmaceuticals Chart

1 Month Vertex Pharmaceuticals Chart

1 Month Vertex Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock